Aetion Announces 5-Year Real-World Evidence Collab with FDA

Aetion has announced a new partnership with the US Food and Drug Administration’s (FDA’s) Oncology Center of Excellence (OCE) to promote oncology care and prevention through its real-world evidence (RWE) offerings. As part of the 5-year collaboration, the OCE will have access to the company’s Evidence Platform. This move adds another team-up for Aetion.

According to Jessica Hagen, “In 2019, Sanofi merged its real-world data platform with Aetion’s Evidence Platform. Sanofi’s real-world data platform, DARWIN, provided de-identified patient data that Aetion’s Evidence Platform would analyze for insights on drug effectiveness, safety and value.”

To read more, click here.

(Source: Mobi Health News, January 24^th, 2023)